Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10024983HBVENSG00000160870.15protein_codingCYP3A7NoNo1551P24462
TVIS10030904HBVENSG00000160870.15protein_codingCYP3A7NoNo1551P24462
TVIS30009372HIVENSG00000160870.15protein_codingCYP3A7NoNo1551P24462
TVIS30067564HIVENSG00000160870.15protein_codingCYP3A7NoNo1551P24462
TVIS30067565HIVENSG00000160870.15protein_codingCYP3A7NoNo1551P24462
TVIS30067566HIVENSG00000160870.15protein_codingCYP3A7NoNo1551P24462
TVIS20043302HPVENSG00000160870.15protein_codingCYP3A7NoNo1551P24462
TCGA Plot Options
Drug Information
GeneCYP3A7
DrugBank IDDB09065
Drug NameCobicistat
Target IDBE0003612
UniProt IDP24462
Regulation Typeinhibitor
PubMed IDs28627229; 20043009
CitationsTseng A, Hughes CA, Wu J, Seet J, Phillips EJ: Cobicistat Versus Ritonavir: Similar Pharmacokinetic Enhancers But Some Important Differences. Ann Pharmacother. 2017 Nov;51(11):1008-1022. doi: 10.1177/1060028017717018. Epub 2017 Jun 19.@@Mathias AA, German P, Murray BP, Wei L, Jain A, West S, Warren D, Hui J, Kearney BP: Pharmacokinetics and pharmacodynamics of GS-9350: a novel pharmacokinetic enhancer without anti-HIV activity. Clin Pharmacol Ther. 2010 Mar;87(3):322-9. doi: 10.1038/clpt.2009.228. Epub 2009 Dec 30.
GroupsApproved
Direct ClassificationN-carbamoyl-alpha amino acids and derivatives
SMILESCC(C)C1=NC(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)CC2=CC=CC=C2)=CS1
Pathways
PharmGKBPA166165092
ChEMBLCHEMBL2095208